Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Hunter

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
AJR. American Journal of Roentgenology|April 22, 2003
Web-based image review and data acquisition for multiinstitutional researchC Craig Blackmore, Michael L Richardson, Ken F Linnau, et al.
The British Journal of Radiology|April 26, 2016
High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot studyAbhijit J Chaudhari, Andrea Ferrero, Felipe Godinez, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 12, 2009
Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia?Alexandre A Steiner, John C Hunter, Sean M Phipps, et al.
Pain|October 21, 2020
Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of painJacob T Beckley, Hassan Pajouhesh, George Luu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12CJohn C Hunter, Deepak Gurbani, Scott B Ficarro, et al.
British Journal of Pharmacology|May 8, 2024
ST-2560, a selective inhibitor of the Na<sub>V</sub>1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primatesJohn V Mulcahy, Jacob T Beckley, Sheri D Klas, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2014
Pharmacological evaluation of selective α2c-adrenergic agonists in experimental animal models of nasal congestionYanlin Jia, Garfield G Mingo, John C Hunter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2010
High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritisAbhijit J Chaudhari, Spencer L Bowen, George W Burkett, et al.
Cell|January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRASChiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
Experimental Neurology|July 27, 2010
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disordersRobert A Hodgson, Paul J Bedard, Geoffrey B Varty, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
AJR. American Journal of Roentgenology|April 22, 2003
Web-based image review and data acquisition for multiinstitutional researchC Craig Blackmore, Michael L Richardson, Ken F Linnau, et al.
The British Journal of Radiology|April 26, 2016
High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot studyAbhijit J Chaudhari, Andrea Ferrero, Felipe Godinez, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 12, 2009
Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia?Alexandre A Steiner, John C Hunter, Sean M Phipps, et al.
Pain|October 21, 2020
Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of painJacob T Beckley, Hassan Pajouhesh, George Luu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12CJohn C Hunter, Deepak Gurbani, Scott B Ficarro, et al.
British Journal of Pharmacology|May 8, 2024
ST-2560, a selective inhibitor of the Na<sub>V</sub>1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primatesJohn V Mulcahy, Jacob T Beckley, Sheri D Klas, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2014
Pharmacological evaluation of selective α2c-adrenergic agonists in experimental animal models of nasal congestionYanlin Jia, Garfield G Mingo, John C Hunter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2010
High-resolution (18)F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritisAbhijit J Chaudhari, Spencer L Bowen, George W Burkett, et al.
Cell|January 17, 2018
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRASChiara Ambrogio, Jens Köhler, Zhi-Wei Zhou, et al.
Experimental Neurology|July 27, 2010
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disordersRobert A Hodgson, Paul J Bedard, Geoffrey B Varty, et al.
Pageof 6